US Map / Arkansas
State AR

Clinical Trials in Arkansas

Recruiting clinical trials with at least one study location in Arkansas. Data updated daily from ClinicalTrials.gov.

Total Trials
121
Recruiting Now
121
← Back to US Map
Top Conditions in Arkansas
Schizophrenia (4)Bipolar I Disorder (3)Breast Cancer (3)Duchenne Muscular Dystrophy (3)Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)Stage II Lip and Oral Cavity Cancer AJCC v8 (2)Stage IV Lung Cancer AJCC v8 (2)Non-Muscle Invasive Bladder Urothelial Carcinoma (2)Major Depressive Disorder (2)Chronic Lymphocytic Leukemia (2)Depression (2)

Frequently Asked Questions — Clinical Trials in Arkansas

How many clinical trials are currently recruiting in Arkansas?
ClinicalMetric currently tracks 121 actively recruiting clinical trials with at least one location in Arkansas. The total number of registered studies—including active but not currently enrolling trials—is 121. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arkansas?
Arkansas hosts clinical trials across a broad range of medical conditions, including Schizophrenia, Bipolar I Disorder, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arkansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arkansas?
To join a clinical trial in Arkansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arkansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Arkansas

NCT04647227 Phase 4
Recruiting
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Condition
Hemophilia A With Inhibitor
Enrollment
55 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
View Trial →
NCT07288138 Phase 2
Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...
Condition
Metabolic Dysfunction-associated Steatohepatitis
Enrollment
160 pts
Location
United States
Sponsor
Eccogene
View Trial →
NCT02986984 N/A
Recruiting
Transformative Research in Diabetic Nephropathy
Condition
Diabetic Nephropathies
Enrollment
400 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT04634552 Phase 2
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myel...
Condition
Hematological Malignancies
Enrollment
510 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
View Trial →
NCT03949855 Phase 2
Recruiting
Belimumab With Rituximab for Primary Membranous Nephropathy
Condition
Membranous Nephropathy
Enrollment
58 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT06012240 Phase 3
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adul...
Condition
Alopecia Areata
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
View Trial →
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04174157 N/A
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Condition
Spinal Muscular Atrophy (SMA)
Enrollment
700 pts
Location
United States, Greece, Ireland
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
View Trial →
NCT04777357 Phase 3
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Carip...
Condition
Depression
Enrollment
380 pts
Location
United States, Puerto Rico, Russia
Sponsor
AbbVie
View Trial →
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
View Trial →
NCT07467993 Phase 2
Recruiting
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Ho...
Condition
Schizophrenia
Enrollment
142 pts
Location
United States
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07076121 Phase 2, Phase 3
Recruiting
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine ...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06315738 Phase 1, Phase 2
Recruiting
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in I...
Condition
Necrotizing Enterocolitis
Enrollment
36 pts
Location
United States
Sponsor
Noveome Biotherapeutics, forme
View Trial →
NCT06596252 Phase 3
Recruiting
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of...
Condition
Eosinophilic Esophagitis
Enrollment
308 pts
Location
United States, Spain
Sponsor
Dr. Falk Pharma GmbH
View Trial →
NCT04333537 Phase 2, Phase 3
Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Pat...
Condition
Buccal Mucosa Squamous Cell Carcinoma
Enrollment
686 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT07298395 Phase 2
Recruiting
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Condition
Atopic Dermatitis (AD)
Enrollment
60 pts
Location
United States
Sponsor
Enveda Therapeutics
View Trial →
NCT03339128 Phase 2
Recruiting
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bow...
Condition
Irritable Bowel Syndrome
Enrollment
95 pts
Location
United States, Bulgaria, Canada
Sponsor
AbbVie
View Trial →
NCT05848687 Phase 1, Phase 2
Recruiting
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Condition
Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Canada
Sponsor
Tanja Andrea Gruber
View Trial →
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT06951711 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic ...
Condition
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Enrollment
274 pts
Location
United States, Croatia, India
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05339139 Phase 3
Recruiting
SAfety of Regional Citrate Anticoagulation (SARCA Study)
Condition
Acute Kidney Injury
Enrollment
50 pts
Location
United States
Sponsor
Fresenius Medical Care North A
View Trial →
NCT07327489 N/A
Recruiting
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Condition
Cancer
Enrollment
2,000 pts
Location
United States
Sponsor
Elephas
View Trial →
Page 2 of 5 — 121 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology